Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Short Interest Update

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 122,300 shares, an increase of 86.7% from the September 15th total of 65,500 shares. Based on an average daily trading volume, of 115,500 shares, the days-to-cover ratio is currently 1.1 days. Currently, 0.7% of the company’s shares are sold short.

Inspira Technologies Oxy B.H.N. Price Performance

Shares of NASDAQ IINN opened at $1.37 on Monday. The company has a current ratio of 2.23, a quick ratio of 2.13 and a debt-to-equity ratio of 0.09. The business’s 50 day moving average price is $1.17 and its 200-day moving average price is $1.54. Inspira Technologies Oxy B.H.N. has a fifty-two week low of $0.76 and a fifty-two week high of $2.49.

Institutional Investors Weigh In On Inspira Technologies Oxy B.H.N.

An institutional investor recently bought a new position in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC purchased a new position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.19% of Inspira Technologies Oxy B.H.N. as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 12.72% of the company’s stock.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.